Michael Eggert

Sentara Norfolk General Hospital — United States

Medicine · Health Sciences

12h-index753citations54works0.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(27), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(6), Vascular Anomalies and Treatments(5), Cardiovascular Issues in Pregnancy(4), Infant Nutrition and Health(3)

Publications52 total

BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension
Respiratory Medicine·2025· 3 citedOpen Access
Unexpected Vasodilator Response in a 38-year-old Female With Longstanding Restrictive Lung Disease and Elevated Right Heart Pressures
American Journal of Respiratory and Critical Care Medicine·2025
Maternal Pulmonary Arterial Hypertension Treated With IV Epoprostenol – A Case Report
American Journal of Respiratory and Critical Care Medicine·2025
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry
UNC Libraries·2025Open Access
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry
UNC Libraries·2025Open Access
LONG-TERM OUTCOMES AND DOSING IN THE BREEZE STUDY OPTIONAL EXTENSION PHASE
CHEST Journal·2024
Pulmonary Hypertension Secondary to Congenital Unilateral Absence of the Right Pulmonary Artery
2024
Differences in Patient Characteristics and Clinical Outcomes at the Extremes of Physical Activity in Pulmonary Arterial Hypertension (PAH): A Pulmonary Hypertension Association Registry (PHAR) Study
2024
PULMONARY HYPERTENSION OF THE CARCINOID HEART: FLEETING AFFAIR OR ENDURING RELATIONSHIP?
CHEST Journal·2023Open Access
The Safety and Efficacy of Inhaled Treprostinil in Patients With PH-ILD on Supplemental Oxygen: A Post-hoc Analysis of the INCREASE Study
2023
In the Shadow of MEN; A Case Report on Chronic Thromboembolic Disease Associated With Multiple Endocrine Neoplasia, Type 1
2023
Coping Phenotypes Are Associated With Health-related Quality of Life in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR)
2023
DAH in PAH: Vaping Associated Lung Injury in a PAH Patient
2023· 1 cited
Dose-response Analyses of Treprostinil Inhalation Powder in PAH and Its Effect on 6MWD
2023
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry
Pulmonary Circulation·2022Open Access
Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry
Journal of the American Heart Association·2022· 215 citedOpen Access
BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
Pulmonary Circulation·2022· 31 citedOpen Access
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat
Pulmonary Circulation·2022· 13 citedOpen Access
Narrative Scharniere – Zur Vermittlung von Emotionalität und Zukunftsperspektiven
Zukunft und Forschung·2022· 2 cited
Health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)
Pulmonary Circulation·2021· 5 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jean Elwing(15), Jeffrey S. Sager(15), Robert P. Frantz(14), Gautam Ramani(14), Charles D. Burger(14), Matthew R. Lammi(14), Murali M. Chakinala(13), Teresa De Marco(13), Sonja Bartolome(13), David B. Badesch(12), Thenappan Thenappan(12), Evelyn M. Horn(12), James R. Klinger(11), Sula Mazimba(11), Nadine Al‐Naamani(11), Todd M. Bull(10), Stephen C. Mathai(10), John Ryan(10), James Runo(10), Kenneth W. Presberg(10)